7 news items
MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA's Approval of a Telomerase Inhibitor Agent Therapy
MAIA
7 Jun 24
or our industry's actual results, levels or activity, performance or achievements to be materially different from those anticipated by such statements
MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent
MAIA
6 Jun 24
actual results, levels or activity, performance or achievements to be materially different from those anticipated by such statements. The use of words
MAIA Biotechnology Reveals New Clinical Data Showing THIO's Strong Efficacy in Non-Small Cell Lung Cancer
MAIA
4 Jun 24
, performance or achievements to be materially different from those anticipated by such statements. The use of words such as "may," "might," "will," "should
Treatment.com AI's (CSE: TRUE) Strategic Partnership with Novus Health, New Board Appointment, and Major Contract To Revolutionize Healthcare, Driving Momentum in the Industry
CBAT
MAIA
NTRB
4 Jun 24
losses arising from an investor’s reliance on the use of this material. Starting on Mar 15, 2024 The Bull Report has been compensated $47,000 per
MAIA Biotechnology to Present at the BIO International Convention 2024
MAIA
17 May 24
, performance or achievements to be materially different from those anticipated by such statements. The use of words such as "may," "might
z1lpzwzt9prznpl7d0hp3gu8kj3lpriakvei90 b0zneaif7ub7ovbg
MAIA
16 May 24
, uncertainties, and other factors that may cause our or our industry's actual results, levels or activity, performance or achievements to be materially
uwqnrb5
MAIA
5 Apr 24
cause our or our industry's actual results, levels or activity, performance or achievements to be materially different from those anticipated
- Prev
- 1
- Next